Development of a CRISPR/Cpf1 system for targeted gene disruption in Aspergillus aculeatus TBRC 277

CRISPR-Cas genome editing technologies have revolutionized biotechnological research particularly in functional genomics and synthetic biology. As an alternative to the most studied and well-developed CRISPR/Cas9, a new class 2 (type V) CRISPR-Cas system called Cpf1 has emerged as another versatile...

Full description

Saved in:
Bibliographic Details
Published inBMC biotechnology Vol. 21; no. 1; p. 15
Main Authors Abdulrachman, Dede, Eurwilaichitr, Lily, Champreda, Verawat, Chantasingh, Duriya, Pootanakit, Kusol
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.02.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…